T1	PROC 1 12	Tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	CHEM 31 43	sitagliptina
#2	AnnotatorNotes T2	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T3	CHEM 48 58	metformina
#3	AnnotatorNotes T3	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T4	DISO 101 132	síndrome de ovario poliquístico
#4	AnnotatorNotes T4	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T5	CHEM 1283 1292	exenatide
#5	AnnotatorNotes T5	C0167117; exenatide; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T6	DISO 187 204	diabetes mellitus
#6	AnnotatorNotes T6	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T7	DISO 207 227	diabetes gestacional
#7	AnnotatorNotes T7	C0085207; Gestational Diabetes; Disease or Syndrome
T8	PROC 232 246	estudio piloto
#8	AnnotatorNotes T8	C0031928; Pilot Projects; Research Activity
T9	CHEM 286 298	sitagliptina
#9	AnnotatorNotes T9	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T10	CHEM 325 335	metformina
#10	AnnotatorNotes T10	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T11	DISO 351 370	ovario poliquístico
#11	AnnotatorNotes T11	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T12	ANAT 397 404	ovárica
#12	AnnotatorNotes T12	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T13	CHEM 462 472	metformina
#13	AnnotatorNotes T13	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T14	DISO 497 528	síndrome de ovario poliquístico
#14	AnnotatorNotes T14	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T15	DISO 530 533	SOP
#15	AnnotatorNotes T15	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T16	DISO 735 747	infertilidad
#16	AnnotatorNotes T16	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T17	PROC 801 812	tratamiento
#17	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 858 868	metformina
#18	AnnotatorNotes T18	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T19	CHEM 871 883	pioglitazona
#19	AnnotatorNotes T19	C0071097; pioglitazone; Organic Chemical · Pharmacologic Substance
T20	DISO 977 996	ovario poliquístico
#20	AnnotatorNotes T20	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T21	CHEM 1002 1012	incretinas
#21	AnnotatorNotes T21	C1562292; Incretins; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Hormone
T22	CHEM 1019 1042	inhibidores de la DPP-4
#22	AnnotatorNotes T22	C1827106; Dipeptidyl-Peptidase IV Inhibitors; Pharmacologic Substance
T23	ANAT 1085 1105	célula β pancreática
T24	Observation 1121 1136	pérdida de peso
#23	AnnotatorNotes T24	C1262477; Weight decreased; Finding
T25	PROC 1180 1195	control de peso
#24	AnnotatorNotes T25	C0920298; Weight maintenance regimen; Therapeutic or Preventive Procedure
T26	CHEM 1319 1329	metformina
#25	AnnotatorNotes T26	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T27	PROC 1336 1347	tratamiento
#26	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	DISO 1351 1354	SOP
#27	AnnotatorNotes T28	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T29	CHEM 1390 1402	sitagliptina
#28	AnnotatorNotes T29	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T30	CHEM 1405 1415	metformina
#29	AnnotatorNotes T30	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T31	PROC 1461 1509	Ensayo clínico cegado, controlado y aleatorizado
#30	AnnotatorNotes T31	C0150108; Blinded; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T32	PROC 1580 1591	diagnóstico
#31	AnnotatorNotes T32	C0011900; Diagnosis; Diagnostic Procedure
T33	DISO 1595 1598	SOP
#32	AnnotatorNotes T33	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T34	PROC 1785 1797	tratamientos
#33	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	CHEM 1847 1857	metformina
#34	AnnotatorNotes T35	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T36	CHEM 1888 1900	sitagliptina
#35	AnnotatorNotes T36	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T37	PROC 2028 2039	tratamiento
#36	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	CHEM 2087 2099	sitagliptina
#37	AnnotatorNotes T38	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T39	DISO 2117 2120	SOP
#38	AnnotatorNotes T39	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T40	CHEM 2136 2146	metformina
#39	AnnotatorNotes T40	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T41	CHEM 2167 2177	metformina
#40	AnnotatorNotes T41	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T42	CHEM 2178 2190	sitagliptina
#41	AnnotatorNotes T42	C1565750; sitagliptin; Organic Chemical · Pharmacologic Substance
T43	PROC 2251 2263	tratamientos
#42	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	ANAT 113 119	ovario
#43	AnnotatorNotes T44	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T45	PROC 258 282	Determinar la eficiencia
T46	ANAT 351 357	ovario
#44	AnnotatorNotes T46	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T47	ANAT 509 515	ovario
#45	AnnotatorNotes T47	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T48	CHEM 817 856	fármacos sensibilizadores a la insulina
T49	ANAT 977 983	ovario
#46	AnnotatorNotes T49	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T51	PROC 1566 1569	IMC
#47	AnnotatorNotes T51	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T52	LIVB 87 96	pacientes
#48	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Spec_cue 163 169	riesgo
T54	LIVB 339 346	mujeres
#49	AnnotatorNotes T54	C0043210; Woman; Population Group
T55	PHYS 406 416	fertilidad
#50	AnnotatorNotes T55	C0015895; Fertility; Organism Function
T56	LIVB 580 587	mujeres
#51	AnnotatorNotes T56	C0043210; Woman; Population Group
T57	Age 591 608	edad reproductiva
T58	LIVB 687 694	mujeres
#52	AnnotatorNotes T58	C0043210; Woman; Population Group
T59	PHYS 895 915	ciclicidad menstrual
#53	AnnotatorNotes T59	C0205836; Ovarian Cycle; Physiologic Function
T60	PHYS 921 931	fertilidad
#54	AnnotatorNotes T60	C0015895; Fertility; Organism Function
T61	LIVB 963 972	pacientes
#55	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	PHYS 1220 1230	fertilidad
#56	AnnotatorNotes T62	C0015895; Fertility; Organism Function
T63	LIVB 1512 1521	Pacientes
#57	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1523 1530	Mujeres
#58	AnnotatorNotes T64	C0043210; Woman; Population Group
T65	Age 1537 1549	18 - 40 años
T66	PHYS 1674 1688	menstruaciones
#59	AnnotatorNotes T66	C0025344; Menstruation; Organism Function
T68	LIVB 2103 2112	pacientes
#60	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	PHYS 2223 2232	ovulación
#61	AnnotatorNotes T69	C0029965; Ovulation; Organ or Tissue Function
T70	PHYS 938 955	perfil metabólico
#62	AnnotatorNotes T70	C3853758; Metabolic Profile; Physiologic Function
T71	PHYS 386 404	ciclicidad ovárica
#63	AnnotatorNotes T71	C0205836; Ovarian Cycle; Physiologic Function
T72	PHYS 419 442	perfil cardiometabólico
#64	AnnotatorNotes T72	C3853758; Metabolic Profile; Physiologic Function (?)
T67	PHYS 216 227	gestacional
#65	AnnotatorNotes T67	C0032961; Pregnancy; Organism Function
T50	PROC 1237 1244	pruebas
#66	AnnotatorNotes T50	C0681814; research study; Research Activity (?)
A1	Assertion T6 Speculated
A2	Assertion T7 Speculated
T73	Neg_cue 1950 1952	No
T74	CONC 1968 1979	diferencias
A3	Assertion T74 Negated
#67	AnnotatorNotes T74	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T73 Arg2:T74	
T75	LIVB 2018 2039	grupos de tratamiento
#68	AnnotatorNotes T75	C5205742; Treatment Group; Population Group
R2	Used_for Arg1:T2 Arg2:T1	
R3	Combined_with Arg1:T2 Arg2:T3	
T76	Quantifier_or_Qualifier 60 65	solas
R4	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T76	
R5	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T76	
R6	Experiences Arg1:T52 Arg2:T4	
R7	Location_of Arg1:T44 Arg2:T4	
R8	Speculation Arg1:T53 Arg2:T6	
R9	Speculation Arg1:T53 Arg2:T7	
R11	Experiences Arg1:T52 Arg2:T1	
T77	Quantifier_or_Qualifier 299 303	sola
R12	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T77	
R13	Combined_with Arg1:T9 Arg2:T10	
R14	Experiences Arg1:T54 Arg2:T9	
R15	Experiences Arg1:T54 Arg2:T11	
R16	Location_of Arg1:T46 Arg2:T11	
R17	Location_of Arg1:T12 Arg2:T71	
R18	Experiences Arg1:T54 Arg2:T71	
R19	Experiences Arg1:T54 Arg2:T55	
R20	Experiences Arg1:T54 Arg2:T72	
R21	Experiences Arg1:T54 Arg2:T13	
T78	Quantifier_or_Qualifier 473 477	sola
R22	Has_Age Arg1:T64 Arg2:T65	
T79	Result_or_Value 1570 1573	>20
R23	Has_Result_or_Value Arg1:T51 Arg2:T79	
R24	Experiences Arg1:T64 Arg2:T51	
R25	Experiences Arg1:T64 Arg2:T33	
T80	CONC 1609 1631	criterios de Rotterdam
R26	Used_for Arg1:T80 Arg2:T32	
R27	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T78	
R28	Location_of Arg1:T47 Arg2:T14	
R29	Location_of Arg1:T47 Arg2:T15	
R30	Experiences Arg1:T56 Arg2:T14	
R31	Experiences Arg1:T56 Arg2:T15	
R32	Has_Age Arg1:T56 Arg2:T57	
R33	Experiences Arg1:T58 Arg2:T14	
R34	Experiences Arg1:T58 Arg2:T15	
R35	Causes Arg1:T15 Arg2:T16	
R36	Causes Arg1:T14 Arg2:T16	
R37	Experiences Arg1:T58 Arg2:T16	
R38	Experiences Arg1:T56 Arg2:T16	
R39	Used_for Arg1:T48 Arg2:T17	
R40	Used_for Arg1:T18 Arg2:T17	
R41	Used_for Arg1:T19 Arg2:T17	
R42	Location_of Arg1:T49 Arg2:T20	
R43	Experiences Arg1:T61 Arg2:T20	
R44	Experiences Arg1:T61 Arg2:T70	
R45	Experiences Arg1:T61 Arg2:T60	
R46	Experiences Arg1:T61 Arg2:T59	
R48	Experiences Arg1:T61 Arg2:T17	
#72	AnnotatorNotes T23	C0030281; Structure of beta Cell of islet; Cell | C4253020; Set of type B cells of pancreatic islet; Cell
T85	Observation 1144 1160	efecto anoréxico
R54	Causes Arg1:T85 Arg2:T24	
T86	Observation 1207 1230	mejora de la fertilidad
T87	PHYS 1069 1105	actividad de la célula β pancreática
R55	Causes Arg1:T87 Arg2:T85	
#74	AnnotatorNotes T86	C0520926; Increased fertility; Finding (?)
R56	Causes Arg1:T22 Arg2:T86	
R57	Causes Arg1:T21 Arg2:T86	
T88	Observation 1273 1279	efecto
#75	AnnotatorNotes T88	C1518681; Outcome of Therapy; Finding (?)
R60	Causes Arg1:T5 Arg2:T88	
T89	Quantifier_or_Qualifier 1293 1297	solo
R61	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T89	
R62	Combined_with Arg1:T5 Arg2:T26	
R63	Used_for Arg1:T5 Arg2:T27	
R64	Combined_with Arg1:T29 Arg2:T30	
T90	Quantifier_or_Qualifier 1416 1421	solas
R65	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T90	
R66	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T90	
R67	Used_for Arg1:T29 Arg2:T27	
R68	Causes Arg1:T29 Arg2:T88	
R69	Causes Arg1:T30 Arg2:T88	
R70	Experiences Arg1:T54 Arg2:T10	
R71	Experiences Arg1:T75 Arg2:T37	
T92	Observation 2065 2083	efecto terapéutico
R72	Causes Arg1:T38 Arg2:T92	
R73	Experiences Arg1:T68 Arg2:T38	
R74	Experiences Arg1:T68 Arg2:T92	
R75	Experiences Arg1:T68 Arg2:T39	
R76	Causes Arg1:T40 Arg2:T92	
R77	Experiences Arg1:T68 Arg2:T41	
R78	Combined_with Arg1:T41 Arg2:T42	
R79	Causes Arg1:T41 Arg2:T92	
R80	Experiences Arg1:T68 Arg2:T69	
R81	Used_for Arg1:T38 Arg2:T43	
R82	Used_for Arg1:T40 Arg2:T43	
R83	Used_for Arg1:T41 Arg2:T43	
R84	Used_for Arg1:T3 Arg2:T1	
T93	Quantifier_or_Qualifier 158 162	alto
#77	AnnotatorNotes T93	C0205250; High; Qualitative Concept
R85	Has_Quantifier_or_Qualifier Arg1:T53 Arg2:T93	
T94	Quantifier_or_Qualifier 1980 2011	estadísticamente significativas
A4	Assertion T94 Negated
#78	AnnotatorNotes T94	C0237881; Statistical Significance; Quantitative Concept
R88	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T94	
R89	Negation Arg1:T73 Arg2:T94	
R10	Experiences Arg1:T68 Arg2:T40	
#69	AnnotatorNotes T89	C0205171; Singular; Quantitative Concept
#70	AnnotatorNotes T90	C0205171; Singular; Quantitative Concept
#71	AnnotatorNotes T76	C0205171; Singular; Quantitative Concept
#73	AnnotatorNotes T92	C0235735; Unexpected therapeutic effect; Finding (?)
#76	AnnotatorNotes T78	C0205171; Singular; Quantitative Concept
#79	AnnotatorNotes T77	C0205171; Singular; Quantitative Concept
A5	Experiencer T52 Patient
A6	Experiencer T54 Patient
A7	Experiencer T56 Patient
A8	Experiencer T58 Patient
A9	Experiencer T61 Patient
A10	Experiencer T63 Patient
A11	Experiencer T64 Patient
A12	Experiencer T75 Patient
A13	Experiencer T68 Patient
